News
NutraCea Launches a Potential Blockbuster Product
- CEA100; The Company Expects a Significant Boost in Revenues
EL DORADO HILLS, Calif. --(Business Wire)-- Feb. 5, 2004
NutraCea (OTCBB:NTRZ), a leading nutraceutical research and development company, announced
today the launch of a new potential blockbuster nutraceutical product - CEA100.
"CEA100 combines the nutritional properties of our two flagship products --
RiSolubles and RiceMucil. It is an all-natural stabilized rice bran supplement with over
100 antioxidants, hypoallergenic protein, omega-3 and omega-6 fatty acids, vitamins,
minerals, phytonutrients and more than 20% total dietary fiber -- both soluble and
insoluble. It is easy to enjoy. It blends perfectly with your favorite beverage,"
says John Howell, President and Chief Operating Officer of NutraCea.
"We expect CEA100 to become one of our best-selling
products. We believe the new product launch should increase our revenues and boost our
profitability. CEA100 enhances the flavor and bioavailability of one of nature's most
nutrient dense foods, stabilized rice bran. It is therefore better value for our customers
but at the same time, less expensive for us to produce. The direct mail campaign to our
existing customers is already underway," states Howell.
CEA100 may provide relief for various disease states. In
fact, according to Dr. Rukmini Cheruvanky, Chief Science Officer of NutraCea, "Cea100
contains high quantities of protein, dietary fiber (both soluble and insoluble), water
soluble vitamins such as B-Complex vitamins, fat-soluble Vitamin E, phytosterols and
important minerals such as potassium, magnesium, manganese and phosphorous.
Synergistically, these nutrients help to provide considerable energy as well as nutrition
for the body to help achieve optimum health. These highly bioavailable phytonutrients also
elicit greater physiological impact in normalizing cholesterol levels, modulating glucose
metabolism and improving the immune function in addition to providing the nutrition for
increased energy and overall health. In other words, it can help reduce cholesterol, and
it can help to reduce the blood sugar levels of insulin and non-insulin dependent
diabetics."
NutraCea is the company behind revolutionary
nutraceutical products that are safe, non-toxic and all-natural, which the company
believes may provide it with a competitive edge over traditional pharmaceutical solutions.
The company has conducted scientific research to discover how the nutrients in its
products help the human body heal itself. The results from limited clinical trials are
astonishing: NutraCea's products may provide significant relief for type 1 and type 2
diabetes by lowering blood glucose levels. They may also impact various cardiovascular
diseases by lowering cholesterol, triglyceride and apolipoprotein B levels. The company's
products may also help the body maximize health by normalizing weight and metabolism as
well as enhancing liver and immune functions.
NutraCea doesn't expect to become a serious challenger
for existing pharmaceutical solutions. However, the company's goal is to become the market
leader in the all-natural and non-toxic nutraceutical segment of the overall market.
NutraCea's breakthrough nutraceutical products consist of
stabilized rice bran derivatives. Rice bran is the most potent source of phytonutrients
and antioxidants found in any food today. Unfortunately, it has been unusable for human
consumption in the past because an enzyme in the brown rice kernel renders the bran rancid
within hours of milling. NutraCea's products retain the vital nutrients of rice bran in a
uniquely bioavailable form due to a major breakthrough in advanced processing technology.
The company has subsequently launched a wide variety of nutraceutical products based on
stabilized rice bran.
To learn more about NutraCea's products, visit http://www.nutraceacorp.com.
The matters set forth in this press release are
forward-looking statements within the meaning of the "safe harbor" provisions of
the Private Securities Litigation Reform Act of 1995. These forward-looking statements are
subject to risks and uncertainties that may cause actual results to differ materially.
These risks are detailed from time to time in the company's periodic reports filed with
the Securities and Exchange Commission including the company's Annual Report, Quarterly
Reports and other periodic filings. These forward-looking statements speak only as of the
date hereof. The company disclaims any intent or obligation to update these
forward-looking statements.
FDA Health Disclaimer: NutraCea's product related
statements have not been evaluated by the Food and Drug Administration. The company's
products are not intended to diagnose, treat, cure, or prevent any disease. Consult your
physician before using any nutraceutical products.
